Skip to main content
Medivolve Inc. logo

Medivolve Inc. — Investor Relations & Filings

Ticker · MEDVF ISIN · CA58503M4083 NEO Human health and social work activities
Open in API
Filings indexed 430 across all filing types
Latest filing 2024-08-31 Board/Management Inform…
Country CA Canada
Listing NEO MEDVF

About Medivolve Inc.

https://questcapinc.com

Medivolve Inc. is a healthcare technology company and principal investment firm focused on the healthcare, industrials, and information technology sectors. The company seeks to reinvent the U.S. healthcare system by developing and leveraging disruptive technologies. Its core services include operating a bespoke telehealth platform and a clinical diagnostic network, which provides diagnostic testing services. The company's operations also include Medivolve Pharmacy Inc., which operates as Marbella Pharmacy.

Recent filings

Filing Released Lang Actions
News release - English.pdf
Board/Management Information Classification · 100% confidence The document is a short announcement about a change in the company's management, specifically the resignation of the president and CEO and his continued role as a consultant. There is no financial data, no mention of reports, or regulatory filings. The content clearly fits the category of announcing changes in the company's board or senior management.
2024-08-31 English
52-109F2 - Certification of interim filings - CEO (E).pdf
Regulatory Filings
2024-06-01 English
Interim MD&A - English.pdf
Regulatory Filings
2024-06-01 English
Interim financial statements/report – English.pdf
Regulatory Filings
2024-06-01 English
Annual information form - English.pdf
Regulatory Filings
2024-04-30 English
52-109F1 - Certification of annual filings - CFO (E).pdf
Regulatory Filings Classification · 95% confidence The document is a Form 52-109F1 Certification of Annual Filings, signed by the CFO, certifying the review and fairness of the annual filings for the financial year ended December 31, 2023. It references the annual financial statements, annual MD&A, and the issuer's disclosure controls and internal controls over financial reporting. The document is primarily a certification letter confirming the accuracy and completeness of the annual filings rather than the filings themselves. It does not contain actual financial data or detailed financial statements but serves as an attestation. According to the Certification Rule, such officer certifications should be classified as Regulatory Filings (RNS) rather than as the Annual Report (10-K) or Management Reports (MDA). The document length is 4518 characters, which is relatively short and consistent with a certification letter rather than a full report.
2024-04-03 English

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.